ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dumortier, P.
Right arrow Articles by De Vuyst, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dumortier, P.
Right arrow Articles by De Vuyst, P.
Eur Respir J 2003; 22:519-524
Copyright ©ERS Journals Ltd 2003


Trends in asbestos body counts in bronchoalveolar lavage fluid over two decades

P. Dumortier1, J. Thimpont1,2, V. de Maertelaer3 and P. De Vuyst1

1 Chest Dept, Hôpital Erasme, 2 Occupational Diseases Fund, and 3 Biostatistics, Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Faculty of Medicine, Université Libre de Bruxelles

CORRESPONDENCE: P. Dumortier, Chest Dept, Cliniques Universitaires de Bruxelles Hôpital Erasme, Route de Lennik 808, B1070, Brussels, Belgium. Fax: 32 25554411. E-mail: pdumorti@ulb.ac.be

Keywords: asbestos body, bronchoalveolar lavage, mesothelioma, trend

Received: January 8, 2003
Accepted May 14, 2003

As in most western countries, the use of asbestos has decreased in Belgium since the mid 1970's. Successive regulations have lowered the permissible levels of exposure and prohibited the use of various asbestos products.

In order to assess the impact of these prevention measures on the pulmonary fibre burden of asbestos-exposed patients, the bronchoalveolar lavage fluid (BALF) asbestos body (AB) analysis database of the authors' laboratory was reviewed for the period 1983–2000.

A total of 4,772 cases were considered, of which 95% were males. AB concentration exceeded 1 AB·mL BALF–1 in 36.1%. There was essentially no change in the mean concentration of AB over the period evaluated. However, the concentrations in individuals with very high levels decreased over time. This was associated with a shift in exposure categories from primary asbestos workers to those exposed during handling of asbestos-containing materials or to asbestos in place in buildings or industrial sites.

This is consistent with epidemiological data indicating that the number of severe cases of asbestosis caused by very high cumulated doses decreases but that benign pleural diseases and mesothelioma remain the most frequent asbestos-related diseases. Past prevention measures are not expected to have a measurable influence on the incidence of mesothelioma in the near future.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the European Respiratory Society.